A non-invasive skin swab test may make a diagnosis of Parkinson’s disease in as few as three minutes, according…
Articles by Margarida Maia, PhD
IMAC Holdings has completed the dosing of a third and last group of patients who are taking part in…
Patient dosing has begun in a Phase 2a clinical trial testing oral CST-2032 in combination with CST-107 as a potential…
The first patient has been dosed in a clinical trial testing Annovis Bio’s buntanetap as an oral therapy for…
Deep brain stimulation (DBS) may not put people with advanced Parkinson’s disease at a greater risk of excessive drooling,…
Certain genetic mutations may help determine the length of survival in Parkinson’s disease patients, according to findings by a…
Antibodies against certain components of the renin-angiotensin system (RAS), which helps to control blood pressure, are present at higher levels…
About 1 in 3 Parkinson’s disease patients in two Phase 3 trials experienced an “off” episode before going to sleep,…
Stem cells in the lab were turned into nerve cells (neurons) that can make dopamine — the chemical that is…
UCB, a global pharmaceutical company, is looking for men and women with early-stage Parkinson’s disease who want to…